+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 113 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899615
The global urinary tract infection testing market is expected to reach USD 812.01 million by 2030. The market is anticipated to grow at a CAGR of 4.4% from 2023 to 2030. The urinary tract infection (UTI) testing market is witnessing growth due to factors such as rising disease burden, increasing geriatric population, rapid technological advancements, and high R&D investments by key players to introduce novel & innovative products, such as self-testing & rapid Point-of-Care (PoC) devices products.

Urinary tract infection is becoming a common global concern. According to research studies, UTI occurs in one in five adult women at some point in their life. In the U.S., about 25%-40% of women aged 20-40 have suffered a UTI. In the U.S., about 250,000 cases of pyelonephritis are reported every year. In women aged 18-19, its incidence is about 28/10,000, out of which 7% of cases require hospital admission. Genetic and cultural factors may influence its prevalence; for instance, in South Korea, the incidence of pyelonephritis is around 59/10,000. Its recurrence is more common than other UTIs, with the recurrence rate being 5.7% in men and 9% in women.

Patients with diabetes are at increased risk of developing urinary tract infections such as acute cystitis, and therefore, the increasing global prevalence of diabetes is likely to contribute to cystitis growth. According to an NCBI article, type 2 diabetes raises UTI risk and patients with type 2 diabetes experience frequent & severe UTIs. According to the International Diabetes Federation (IDF) data from 2021, approximately 643 million individuals will have diabetes by 2030 and 783 million by 2045. Moreover, the estimated prevalence of asymptomatic bacteriuria in diabetic females is 26%, compared to 6% in nondiabetic females. Such factors are expected to boost the prevalence of cystitis globally.

However, due to the rise in awareness about such diseases, the demand for specialist treatment has increased in recent years. According to the U.S. Department of Health and Human Services, in the U.S., the number of practicing urologists in 2020 was 4.07 per 100,000 populations. The report further stated that due to the rise in demand, a shortage of urologists was observed, which is likely to exceed nearly 3,600 physicians by 2025. This can impede market growth in the coming years. Moreover, COVID-19 has had a detrimental impact on the industry. Individuals with UTIs have experienced substantial disruptions in testing and emergency care.

Key players are introducing novel products to strengthen their portfolios. For instance, in September 2021, OpGen, Inc. announced initiating clinical trials of the Unyvero Urinary Tract Infection Panel. The panel can analyze a broad range of pathogens and antimicrobial resistance markers directly from a urine sample. Successful clinical trials and the launch of such technologically advanced & efficient products are anticipated to drive market growth over the coming years. Similarly, in July 2020, Uqora, Inc. (Pharmavite, LLC), a urinary health biotechnology company, launched a UTI diagnostic and management kit. The kit includes a rapid UTI diagnostic device, Clarify, compatible with a PoC and homecare setting.

Urinary Tract Infection Testing Market Highlights
-Cystitis dominated the market in 2022, with an estimated market share of 41.42%. This can be attributed to the high incidence & recurrence rate of cystitis, increased number of product approvals, and the high number of diabetes patients who are more prone to cystitis
-The reference laboratories segment held a share of 26.66% in 2022 attributed to the ongoing efforts of reference laboratories to enhance patient outcomes by offering diagnostic facilities at retail level.
-North America dominated the overall urinary tract infection market in terms of value. This can be attributed to better reimbursement facilities and a rise in the adoption of novel diagnostic products due to increased awareness

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Urinary Tract Infection Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Urinary Tract Infection Testing Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Urinary Tract Infection Testing: Type Estimates & Trend Analysis
4.1. Urinary Tract Infection Testing Market: Key Takeaways
4.2. Urinary Tract Infection Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Urethritis
4.3.1. Urethritis market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Cystitis
4.4.1. Cystitis market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Pyelonephritis
4.5.1. Pyelonephritis market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Urinary Tract Infection Testing: End Use Estimates & Trend Analysis
5.1. Urinary Tract Infection Testing Market: Key Takeaways
5.2. Urinary Tract Infection Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. General Practitioners (GPs)
5.3.1. General practitioners (GPs) market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Urologists
5.4.1. Urologists market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Urogynecologists
5.5.1. Urogynecologists market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Hospital Laboratories
5.6.1. Hospital laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Reference Laboratories
5.7.1. Reference laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Hospital Emergency Departments
5.8.1. Hospital emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Urgent Care
5.9.1. Urgent care market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Others
5.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Urinary Tract Infection Testing Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Urinary Tract Infection Testing Market by Region: Key Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. QIAGEN
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Accelerate Diagnostics, Inc.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Bio-Rad Laboratories, Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. F. Hoffmann-La Roche Ltd.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Danaher
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Siemens Healthcare GmbH
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Randox Laboratories Ltd.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Thermo Fisher Scientific, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. BIOMÉRIEUX
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. T2 Biosystems, Inc.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 3 North America urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 4 North America urinary tract infection testing market, by region, 2018-2030 (USD Million)
Table 5 U.S. urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 6 U.S. urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 7 Canada urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 8 Canada urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 9 Europe urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 10 Europe urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 11 Europe urinary tract infection testing market, by region, 2018-2030 (USD Million)
Table 12 Germany urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 13 Germany urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 14 UK urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 15 UK urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 16 France urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 17 France urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 18 Italy urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 19 Italy urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 20 Spain urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 21 Spain urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 22 Sweden urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 23 Sweden urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 24 Norway urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 25 Norway urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 26 Denmark urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 27 Denmark urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 28 Asia Pacific urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 29 Asia Pacific urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 30 Asia Pacific urinary tract infection testing market, by region, 2018-2030 (USD Million)
Table 31 China urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 32 China urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 33 Japan urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 34 Japan urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 35 India urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 36 India urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 37 Thailand urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 38 Thailand urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 39 South Korea urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 40 South Korea urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 41 Latin America urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 42 Latin America urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 43 Latin America urinary tract infection testing market, by region, 2018-2030 (USD Million)
Table 44 Brazil urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 45 Brazil urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 46 Mexico urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 47 Mexico urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 48 Argentina urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 49 Argentina urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 50 Middle East and Africa urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 51 Middle East and Africa urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 52 Middle East and Africa urinary tract infection testing market, by region, 2018-2030 (USD Million)
Table 53 South Africa urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 54 South Africa urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 55 Saudi Arabia urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 56 Saudi Arabia urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 57 UAE urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 58 UAE urinary tract infection testing market, by end use, 2018-2030 (USD Million)
Table 59 Kuwait urinary tract infection testing market, by type, 2018-2030 (USD Million)
Table 60 Kuwait urinary tract infection testing market, by end use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Urinary tract infection testing: Market outlook
Fig. 9 Urinary tract infection testing: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Urinary tract infection testing market driver impact
Fig. 15 Urinary tract infection testing market restraint impact
Fig. 16 Urinary tract infection testing market strategic initiatives analysis
Fig. 17 Urinary tract infection testing market: Type movement analysis
Fig. 18 Urinary tract infection testing market: Type outlook and key takeaways
Fig. 19 Urethritis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 Cystitis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Pyelonephritis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 Urinary tract infection testing market: End use movement analysis
Fig. 23 Urinary tract infection testing market: End use outlook and key takeaways
Fig. 24 General practitioners (GPs) market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Urologists market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 Urogynecologists market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Hospital laboratories market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Reference laboratories market estimates and forecasts, 2018-2030 (USD Million)
Fig. 29 Hospital emergency departments market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 Urgent care market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Global urinary tract infection testing market: Regional movement analysis
Fig. 33 Global urinary tract infection testing market: Regional outlook and key takeaways
Fig. 34 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 37 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • QIAGEN
  • Accelerate Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher
  • Siemens Healthcare GmbH
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific, Inc.
  • BIOMÉRIEUX
  • T2 Biosystems, Inc.

Methodology

Loading
LOADING...

Table Information